Skip to main content

The Assistance Fund: Gaucher Disease

The Assistance Fund

OpenVerified·Apr 25, 2026

The Assistance Fund: Gaucher Disease program offers financial assistance for copays, coinsurance, deductibles, health insurance premiums, and incidental medical expenses related to FDA-approved treatments for Gaucher Disease. Eligible patients must be residents of the US or Puerto Rico, have commercial insurance, Medicare, or Medicaid, and meet financial need criteria. The program supports patients prescribed drugs such as Cerezyme, Vpriv, Zavesca, Elelyso, Cerdelga, and Miglustat, and may also cover off-label drugs.

Covers
financial assistance
Enrollment cycle
annual

Apply

Application goes directly to The Assistance Fund. RxCopays does not receive compensation.

Go to application →

Status source

Enrollment Forms Enrollment Form Start Saving

Rare-disease support beyond financial help

This grant covers a rare condition. For specialists, clinical trials, and patient communities, our sister site UniteRare.org has in-depth pages: